Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 866 entries
View as:

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03104413 Org: User:
Start: 12/18/17 End: 05/19/21 Due: 05/19/22

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01682616 Org: User:
Start: 07/25/12 End: 06/23/22 Due: 06/23/23

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT06023030 Org: User:
Start: 07/28/23 End: 11/30/26 Due: 11/30/27

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02581020 Org: User:
Start: 01/14/16 End: 12/08/20 Due: 12/08/21

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT05822752 Org: User:
Start: 09/21/23 End: 11/30/26 Due: 11/30/27

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

Phase: N/A Priority: Normal
NCT ID: NCT05424562 Org: User:
Start: 09/07/22 End: 06/30/26 Due: 06/30/27

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02684370 Org: User:
Start: 02/29/16 End: 09/30/17 Due: 09/30/18

A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Phase: N/A Priority: Normal
NCT ID: NCT03047395 Org: User:
Start: 02/27/17 End: 11/29/23 Due: 11/29/24

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04468984 Org: User:
Start: 08/31/20 End: 12/31/26 Due: 12/31/27

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03310190 Org: User:
Start: 01/10/18 End: 04/30/22 Due: 04/30/23

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02384538 Org: User:
Start: 03/31/15 End: 07/31/16 Due: 07/31/17

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04644120 Org: User:
Start: 12/10/20 End: 08/24/21 Due: 08/24/22

A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT06308198 Org: User:
Start: 03/29/24 End: 02/26/25 Due: 02/26/26

Surveillance of Humira in Korean JIA Patients

Phase: N/A Priority: Normal
NCT ID: NCT02141984 Org: User:
Start: 05/31/14 End: 04/30/16 Due: 04/30/17

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

Phase: N/A Priority: Normal
NCT ID: NCT02349451 Org: User:
Start: 04/28/15 End: 07/04/16 Due: 07/04/17

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02243293 Org: User:
Start: 09/19/14 End: 02/23/17 Due: 02/23/18

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05316220 Org: User:
Start: 09/15/24 End: 07/19/26 Due: 07/19/27

A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02412371 Org: User:
Start: 04/30/15 End: 08/05/19 Due: 08/05/20

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04417465 Org: User:
Start: 06/03/20 End: 05/29/26 Due: 05/29/27

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT02627924 Org: User:
Start: 11/18/15 End: 12/28/17 Due: 12/28/18

Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00437658 Org: User:
Start: 12/11/06 End: 11/24/08 Due: 11/24/09

A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02087904 Org: User:
Start: 06/04/14 End: 12/13/16 Due: 12/13/17

A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression.

Phase: N/A Priority: Normal
NCT ID: NCT04140175 Org: User:
Start: 01/20/20 End: 11/19/20 Due: 11/19/21

A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT02549092 Org: User:
Start: 10/26/15 End: 11/18/22 Due: 11/18/23

Efficacy and Safety Study of Elagolix in Women With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00973973 Org: User:
Start: 10/12/09 End: 09/22/10 Due: 09/22/11